The global biopsy needle market is highly competitive, with numerous players competing to gain a larger market share. Some of the key players in the market include Boston Scientific Corporation, Cook Medical, Dickinson and Company, Medtronic plc, Olympus Corporation, Hologic, Inc., Becton, and Terumo Corporation.
These companies are primarily focusing on product development, collaborations, and strategic partnerships to expand their market presence and increase their revenue. For instance, in September 2020, Boston Scientific Corporation announced the launch of its EXALT™ Model B Single-Use Bronchoscope, which is designed to improve patient care by providing high-quality imaging and minimally invasive procedures.
In addition, companies are also investing in mergers and acquisitions to strengthen their market position. For instance, in December 2019, Cook Medical acquired a medical device company, Endo-Flex GmbH, which is expected to enhance Cook Medical’s offering of minimally invasive solutions for various diseases.
Another important strategy being employed by key players in the biopsy needle market is the development of innovative products. Companies are investing in research and development activities to create new products that meet the changing needs of healthcare professionals and patients. For example, in October 2019, Olympus Corporation launched its EZ Shot 3 Plus 25 G EUS-FNA needle, which is designed to improve the accuracy and efficiency of biopsy procedures.
Moreover, companies are also focusing on expanding their geographic reach through partnerships and collaborations. For instance, in February 2021, Becton, Dickinson and Company entered into a distribution agreement with Helix Medical LLC to expand the availability of its biopsy products in the Asia Pacific region.
The key players in the biopsy needle market are also focused on improving their manufacturing processes to ensure high-quality products that meet regulatory standards. With the increasing demand for personalized medicine, the market is expected to continue to grow, and companies are well-positioned to capitalize on this trend by investing in research and development and strategic partnerships.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Market Insight Lab journalist was involved in the writing and production of this article.